INRATIO PT/INR TEST STRIPS
Report
- Report Number
- 2027969-2016-00689
- Event Type
- Malfunction
- Date Received
- November 22, 2016
- Report Date
- October 26, 2016
- Manufacturer
- ALERE SAN DIEGO, INC.
- Product Code
- GJS
- PMA / PMN Number
- K110212
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GM
- Reporter Occupation
- OTHER
Narratives
INVESTIGATION CONCLUSION: INVESTIGATION PENDING.
INVESTIGATION/CONCLUSION: IT IS INDICATED THAT THE PRODUCT IS NOT RETURNING FOR EVALUATION. THEREFORE, IN-HOUSE TESTING WITH RETAINS OF THE REPORTED LOT WAS PERFORMED. IN-HOUSE STRIP TESTING ON STRIP LOT K392893 MEETS CRITERIA. THE PRODUCT PERFORMED AS EXPECTED. THE MANUFACTURING RECORDS FOR THE LOT WERE REVIEWED AND THE LOT MET RELEASE SPECIFICATIONS. ALTHOUGH A TECHNIQUE ISSUE WAS IDENTIFIED, A ROOT CAUSE COULD NOT BE DETERMINED FROM THE INFORMATION PROVIDED BY THE CUSTOMER. BASED ON THE INFORMATION AVAILABLE, THERE IS NO INDICATION OF A PRODUCT DEFICIENCY. NO CORRECTIVE ACTION IS REQUIRED AT THIS TIME.
REPORT RECEIVED OF DISCREPANT INRATIO VALUES. EVENT OCCURRED IN (B)(6). PATIENT'S THERAPEUTIC RANGE 2 - 3. PATIENT REPORTS TWO DISCREPANT INRATIO INR RESULTS COMPARED TO LABORATORY INR. TESTS TAKEN DURING A 4 WEEK REHABILITATION PERIOD IN A REHAB CLINIC (REASON FOR REHAB UNKNOWN). DATES FOR TESTS NOT PROVIDED. NUMBER OF DAYS BETWEEN THE TWO TEST RESULTS UNKNOWN. RESULT 1: INRATIO INR = 1.7; LAB INR = 2.5. RESULT 2: INRATIO INR = 2.6; LAB INR = 1.3. NO REPORTED ADVERSE PATIENT SEQUELA. NO ADDITIONAL INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 771135 | INRATIO PT/INR TEST STRIPS | PROTHROMBIN TIME TEST | GJS | ALERE SAN DIEGO, INC. | 99008G1 | K392893 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | INRATIO MONITOR SERIAL # (B)(4) |